Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation.
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2015
At a glance
- Drugs Rotigotine (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Acronyms AURORA
- Sponsors UCB
- 20 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology (AAN), according to a UCB media release.
- 03 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Aug 2013 Planned End Date changed from 1 Jul 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.